Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 354, pseudogene (RNU6-354P) is a processed genomic pseudogene in human genome, related in sequence to the U6 small nuclear RNA (snRNA) gene but inactivated by mutations or genomic rearrangements such that it does not produce functional RNA or protein. U6 snRNA itself plays an essential role in the spliceosome, which is responsible for pre-mRNA splicing in eukaryotes, but pseudogenes like RNU6-354P are generally transcriptionally silent or may produce non-functional transcripts. While some pseudogenes may participate in gene regulation or disease by acting as competing endogenous RNAs (ceRNAs), there is no evidence that RNU6-354P is functional or relevant as a therapeutic target or biomarker[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 354, pseudogene (RNU6-354P).